您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2020, Vol. 1 ›› Issue (7): 67-71.doi: 10.6040/j.issn.1671-7554.0.2020.0486

• • 上一篇    下一篇

101例脑小血管病患者脑微出血危险因素的回顾性分析

徐玉香1,2,刘煜东1,3,张蓬1,3,段瑞生1,3   

  1. 1. 山东大学附属山东省千佛山医院神经内科, 山东 济南 250014;2. 济南市第五人民医院神经内科, 山东 济南 250022; 3. 山东第一医科大学第一附属医院神经内科, 山东 济南 250014
  • 出版日期:2020-07-20 发布日期:2020-07-10
  • 通讯作者: 段瑞生. E-mail:ruisheng_duan@ yahoo.com
  • 基金资助:
    山东第一医科大学学术提升计划(2019QL013)

A retrospective analysis of risk factors of cerebral microbleeds in 101 patients with cerebral small vessel disease

XU Yuxiang1,2, LIU Yudong1,3, ZHANG Peng1,3, DUAN Ruisheng1,3   

  1. 1. Department of Neurology, Shandong Qianfoshan Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250014, Shandong, China;
    2. Department of Neurology, The 5th Peoples Hospital of Jinan, Jinan 250022, Shandong, China;
    3. Department of Neurology, The First Affiliated Hospital of Shandong First Medical University, Jinan 250014, Shandong, China
  • Online:2020-07-20 Published:2020-07-10

摘要: 目的 探讨脑小血管病(CSVD)患者脑微出血(CMBs)的独立危险因素。 方法 回顾性收集符合脑小血管病影像学诊断的患者101例,按是否存在CMBs分为CMBs组和非CMBs组,统计学分析识别CMBs的危险因素和保护因素。 结果 与CSVD中非CMBs组患者比较,CMBs组患者中高血压所占比例较高(χ2=9.879, P=0.002),超敏C反应蛋白(hs-CRP)(t=2.294, P=0.024)、同型半胱氨酸(Hcy)(t=2.193, P=0.031)、半胱氨酸蛋白酶抑制剂C(Cys-C)(t=2.160, P=0.034)、脂蛋白a(Lpa)(t=4.247, P<0.001)水平较高,低密度脂蛋白胆固醇(LDL-c)(t=-3.342, P=0.001)水平较低。Logistic回归分析结果显示,高血压(P=0.002, OR=6.706, 95%CI:2.011~22.362)、hs-CRP(P=0.049, OR=1.279,95%CI:1.001~1.635)、Lpa(P=0.001,OR=1.006,95%CI:1.003~1.009)和LDL-c(P=0.039, OR=0.472,95%CI:0.232~0.963)与CMBs独立相关。 结论 高血压、hs-CRP、Lpa是CMBs的独立危险因素,LDL-c是CMBs的保护因素。

关键词: 脑微出血, 超敏C反应蛋白, 低密度脂蛋白胆固醇, 脂蛋白a

Abstract: Objective To investigate the independent risk factors of cerebral microbleeds(CMBs)in patients with cerebral small vessel disease(CSVD). Methods A total of 101 patients who met the imaging diagnostic criteria of CSVD were divided into CMBs group and non-CMBs group. The risk factors and protective factors of CMBs were identified with statistical analysis. Results Compared with non-CMBs group, CMBs group had a higher incidence of hypertension(χ2=9.879, P=0.002), higher levels of high-sensitivity C-reactive protein(hs-CRP)(t=2.294, P=0.024), homocysteine(Hcy)(t=2.193, P=0.031), cystatin C(Cys-C)(t=2.160, P=0.034)and lipoprotein a(Lpa)(t=4.247, P<0.001), but lower level of low-density lipoprotein cholesterol(LDL-c)(t=-3.342, P=0.001). Logistic regression analysis showed that hypertension(P=0.002, OR=6.706, 95%CI: 2.011-22.362), hs-CRP(P=0.049, OR=1.279, 95%CI:1.001-1.635), Lpa(P=0.001, OR=1.006, 95%CI:1.003-1.009)and LDL-c(P=0.039, OR=0.472, 95%CI: 0.232-0.963)were independently correlated with CMBs. Conclusion Hypertension, hs-CRP and Lpa are the independent risk factors of CMBs, whereas LDL-c is a protective factor.

Key words: Cerebral microbleeds, High-sensitivity C-reactive protein, Low-density lipoprotein cholesterol, Lipoprotein a

中图分类号: 

  • R743.9
[1] Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges [J]. Lancet Neurol, 2010, 9(7): 689-701.
[2] Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration [J]. Lancet Neurol, 2013, 12(8): 822-838.
[3] Martinez-Ramirez S, Pontes-Neto OM, Dumas AP, et al. Topography of dilated perivascular spaces in subjects from a memory clinic cohort [J]. Neurology, 2013, 80(17): 1551-1556.
[4] van Agtmaal MJM, Houben A, Pouwer F, et al. Association of microvascular dysfunction with late-life depression: a systematic review and meta-analysis [J]. JAMA Psychiatry, 2017, 74(7): 729-739.
[5] Lee J, Sohn EH, Oh E, et al. Characteristics of cerebral microbleeds [J]. Dement Neurocogn Disord, 2018, 17(3): 73-82.
[6] Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation [J]. Lancet Neurol, 2009, 8(2): 165-174.
[7] Shoamanesh A, Kwok CS, Benavente O. Cerebral microbleeds: histopathological correlation of neuroimaging [J]. Cerebrovasc Dis, 2011, 32(6): 528-534.
[8] Haller S, Vernooij MW, Kuijer JPA, et al. Cerebral microbleeds: imaging and clinical significance [J]. Radiology, 2018, 287(1): 11-28.
[9] Wu Y, Chen T. An up-to-date review on cerebral microbleeds [J]. J Stroke Cerebrovasc Dis, 2016, 25(6): 1301-1306.
[10] Romero JR, Preis SR, Beiser A, et al. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham Heart Study [J]. Stroke, 2014, 45(5): 1492-1494.
[11] Akoudad S, Darweesh SK, Leening MJ, et al. Use of coumarin anticoagulants and cerebral microbleeds in the general population [J]. Stroke, 2014, 45(11): 3436-3439.
[12] Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting [J]. Brain, 2007, 130(Pt 8): 1988-2003.
[13] Liu W, Liu R, Sun W, et al. Different impacts of blood pressure variability on the progression of cerebral microbleeds and white matter lesions [J]. Stroke, 2012, 43(11): 2916-2922.
[14] Ferretti G, Bacchetti T, Johnston TP, et al. Lipoprotein(a): a missing culprit in the management of athero-thrombosis? [J]. J Cell Physiol, 2018, 233(4): 2966-2981.
[15] Low A, Mak E, Rowe JB, et al. Inflammation and cerebral small vessel disease: a systematic review [J]. Ageing Res Rev, 2019, 53: 100916. doi: 10.1016/j.arr.2019.100916.
[16] Ma C, Na M, Neumann S, et al. Low-density lipoprotein cholesterol and risk of hemorrhagic stroke: a systematic review and dose-response meta-analysis of prospective studies [J]. Curr Atheroscler Rep, 2019, 21(12): 52.
[17] Lee SH, Lee ST, Kim BJ, et al. Dynamic temporal change of cerebral microbleeds: long-term follow-up MRI study [J]. PLoS One, 2011, 6(10): e25930. doi: 10.1371/journal. pone. 0025930.
[18] Bruckdorfer KR, Demel RA, De Gier J, et al. The effect of partial replacements of membrane cholesterol by other steroids on the osmotic fragility and glycerol permeability of erythrocytes [J]. Biochim Biophys Acta, 1969, 183(2): 334-345.
[19] Rosenson RS, Lowe GD. Effects of lipids and lipoproteins on thrombosis and rheology [J]. Atherosclerosis, 1998, 140(2): 271-280.
[20] Lee SH, Bae HJ, Yoon BW, et al. Low concentration of serum total cholesterol is associated with multifocal signal loss lesions on gradient-echo magnetic resonance imaging: analysis of risk factors for multifocal signal loss lesions [J]. Stroke, 2002, 33(12): 2845-2849.
[21] Ma Y, Li Z, Chen L, et al. Blood lipid levels, statin therapy and the risk of intracerebral hemorrhage [J]. Lipids Health Dis, 2016, 15: 43. doi: 10.1186/s12944-016-0213-8.
[22] Mitaki S, Nagai A, Oguro H, et al. C-reactive protein levels are associated with cerebral small vessel-related lesions [J]. Acta Neurol Scand, 2016, 133(1): 68-74.
[23] Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells [J]. Circulation, 2000, 102(18): 2165-2168.
[24] Verma S, Li SH, Badiwala MV, et al. Endothelin antagonism and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein [J]. Circulation, 2002, 105(16): 1890-1896.
[25] Khreiss T, Jozsef L, Potempa LA, et al. Conformational rearrangement in C-reactive protein is required for proinflammatory actions on human endothelial cells [J]. Circulation, 2004, 109(16): 2016-2022.
[26] Kaaouana T, de Rochefort L, Samaille T, et al. 2D harmonic filtering of MR phase images in multicenter clinical setting: toward a magnetic signature of cerebral microbleeds [J]. Neuroimage, 2015, 104: 287-300. doi: 10.1016/j.neuroimage.2014.08.024.
[1] 谢佳莹, 祁佳, 宋铭, 李育林, 王迪, 贾旭, 张薇, 钟明, 尚嫄嫄. 血清蛋白质β-折叠水平与冠心病的相关性[J]. 山东大学学报 (医学版), 2022, 60(1): 21-26.
[2] 王丹,杨晓华,郑云哨,阚伟京,寻广磊. 抑郁症患者血清hs-CRP水平变化及其对抗抑郁药疗效的预测作用[J]. 山东大学学报 (医学版), 2018, 56(6): 51-57.
[3] 段瑞生. 他汀对动脉粥样硬化的免疫调节及其在临床应用中的思考[J]. 山东大学学报(医学版), 2015, 53(5): 1-4.
[4] 吴宏图, 丁娴, 张磊, 曹兴丽, 王峥艳, 单春明, 刘平. 儿童咳嗽变异性哮喘FeNO、hs-CRP及 IgE水平变化及意义[J]. 山东大学学报(医学版), 2014, 52(S2): 82-83.
[5] 吴斌, 何文涛, 程云峰, 章以法, 吴东刚. 肝硬化患者血清高密度脂蛋白胆固醇检测的临床意义[J]. 山东大学学报(医学版), 2014, 52(S2): 19-19.
[6] 张楠1,袁中尚2,张栩1,张祎坤1,于春晓1,高聆3,赵家军1,管庆波1,管理英4. 2型糖尿病男性患者血清睾酮与血脂关系的探讨[J]. 山东大学学报(医学版), 2014, 52(4): 58-61.
[7] 翟茜,李保应,高海青,江蓓. 葡萄子原花青素对糖尿病大鼠主动脉载脂蛋白A-Ⅰ表达的影响[J]. 山东大学学报(医学版), 2009, 47(6): 1-.
[8] 孙秀芳,陈焕芹,李保应,常 静,杨轶文,邱 蕾. 老年人载脂蛋白A5与血脂、脂蛋白及血糖的相关性[J]. 山东大学学报(医学版), 2008, 46(7): 729-732.
[9] 李 慧,徐贵发,刘跟生,张 洁,周湘盈,丰佃娟. 人体血清载脂蛋白A-IV水平与肥胖、瘦素的相关性探讨[J]. 山东大学学报(医学版), 2007, 45(1): 6-09.
[10] 徐贵发,李辉,刘跟生,石劢,李慧. 膳食营养素摄入对人血清载脂蛋白AIV水平的影响[J]. 山东大学学报(医学版), 2006, 44(4): 325-327.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 郑敏,郝跃伟,刘雪平,赵婷婷. 血小板膜糖蛋白Ibα基因HPA-2、Kozak序列多态性与脑梗死的相关性研究[J]. 山东大学学报(医学版), 2008, 46(3): 292 -295 .
[2] 张杰,李振华,孙晋浩,暴丽华,刘岳鹏. 恒定磁场对Schwann细胞氧化损伤的保护作用[J]. 山东大学学报(医学版), 2007, 45(3): 229 -232 .
[3] 方英立,马玉燕,刘锡梅,周文 . 急诊剖宫产患者围手术期替硝唑合理应用[J]. 山东大学学报(医学版), 2007, 45(10): 995 .
[4] 姜红菊,李润智,王营,徐冬梅,张梅,张运,李继福 . 冠状动脉粥样硬化斑块形态及介入治疗与MMP-9的关系[J]. 山东大学学报(医学版), 2008, 46(10): 966 -970 .
[5] 王术芹,齐 峰,吴剑波,孙宝柱. 罗哌卡因对大鼠离体主动脉收缩作用的钙离子调节机制[J]. 山东大学学报(医学版), 2008, 46(8): 773 -776 .
[6] 滕学仁,赵永生,胡光亮,周伦,李建民 . 两种方法保存同种异体髌腱移植重建膝关节交叉韧带的光镜电镜观察[J]. 山东大学学报(医学版), 2008, 46(10): 945 -950 .
[7] 李明霞,王学禹 . 儿童急性播散性脑脊髓炎31例临床与MRI特点[J]. 山东大学学报(医学版), 2008, 46(8): 828 -830 .
[8] . Graves病131治疗后1年内早发甲减影响因素分析[J]. 山东大学学报(医学版), 2009, 47(9): 5 -6 .
[9] 牛瑞,刘波,邵明举,王伟 . 非小细胞肺癌区域淋巴结中肺组织特异性基因的表达与预后的关系[J]. 山东大学学报(医学版), 2007, 45(9): 884 -885 .
[10] 袁吴敏,赵志伦,王洁贞 . 吸烟和饮酒与颅内肿瘤关系的Meta分析[J]. 山东大学学报(医学版), 2006, 44(11): 1146 -1149 .